10 Under-the-Radar Stocks with Massive Upside for 2026
The benchmark 10-year Treasury yield hit its highest level since January 2025 that same week, while the 30-year yield briefly touched its highest since 2007, Reuters reported.
Legend Biotech Corp (LEGN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 7,687,638 | $139,069,371 | +30% | 1.64% |
| 2. | Suvretta Capital Management Aaron Cowen | 7,581,029 | $137,140,815 | +15% | 3.5% |
| 3. | Hillhouse Capital Management Lei Zhang | 5,984,550 | $108,260,510 | 6.47% | |
| 4. | Point72 Asset Management Steve Cohen | 3,886,017 | $70,298,048 | +40% | 0.09% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 1,890,396 | $34,197,264 | +175% | 0.03% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.77 | 9,936 | $87,138.72 | 247,438 | 2026-03-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,696,740 | $464,854,020 | 0.02% | |
| 2. | 5,763,475 | $104,261,271 | 0.44% | |
| 3. | 4,684,543 | $84,743,375 | 0% | |
| 4. | 2,296,335 | $41,540,700 | 1.79% | |
| 5. | 2,254,488 | $40,783,688 | 0.07% |
News See All
Legend Biotech Corporation (NASDAQ:LEGN) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Legend Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.
10 Stocks With Stunning Gains
Ten stocks boasted strong gains on Tuesday, outperforming a lackluster performance on Wall Street, as investors continued to digest a flurry of strong corporate earnings.
10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
10 Stocks With Double-Digit Returns
Ten stocks kicked off the trading week with double-digit gains, defying a lackluster performance on the broader market, as investors turned to positive developments to bolster their buying appetite.
10 Overlooked Growth Stocks to Buy Now
On April 14, Tom Lee, Fundstrat's Head of Research, joined CNBC's 'Power Lunch' to discuss his outlook on equities.
RBC Capital Cuts PT on Legend Biotech Corporation (LEGN) to $62 From $66 - Here's Why
Legend Biotech Corporation (NASDAQ:LEGN) is one of the best high growth healthcare stocks to buy now.
11 High Growth Healthcare Stocks to Buy Now
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities, and the effects ...
Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions
TheFly reported on February 4 that Barclays lowered its price target on LEGN to $80 from $90 and maintained an Overweight rating on the shares. Although the long-term forecast for the company's clinical...
FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)
On January 20, Leonid Timashev of RBC Capital maintained an Outperform rating on Legend Biotech (NASDAQ:LEGN) and set a $66 price target.
Hedge Fund Resource Center